Cognyte Software (NASDAQ:CGNT – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.
Cognyte Software Stock Up 0.4 %
Shares of CGNT traded up $0.03 during trading hours on Tuesday, reaching $5.75. The stock had a trading volume of 619,834 shares, compared to its average volume of 346,085. The firm has a 50-day moving average of $4.64 and a 200 day moving average of $5.00. The company has a market cap of $378.35 million, a P/E ratio of -5.37 and a beta of 1.55. Cognyte Software has a 52 week low of $2.31 and a 52 week high of $6.23.
Cognyte Software (NASDAQ:CGNT – Get Free Report) last released its quarterly earnings data on Tuesday, September 12th. The medical device company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.12. The business had revenue of $77.10 million for the quarter, compared to analysts’ expectations of $73.87 million. Cognyte Software had a negative return on equity of 34.83% and a negative net margin of 24.78%. Cognyte Software’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.43) EPS. As a group, equities analysts expect that Cognyte Software will post -0.5 earnings per share for the current year.
Institutional Trading of Cognyte Software
A number of institutional investors have recently modified their holdings of CGNT. Citigroup Inc. lifted its stake in Cognyte Software by 3.0% in the 3rd quarter. Citigroup Inc. now owns 138,749 shares of the medical device company’s stock valued at $667,000 after acquiring an additional 3,993 shares in the last quarter. Phoenix Holdings Ltd. boosted its holdings in Cognyte Software by 33.0% during the third quarter. Phoenix Holdings Ltd. now owns 279,400 shares of the medical device company’s stock worth $1,344,000 after purchasing an additional 69,400 shares during the last quarter. Walleye Capital LLC grew its position in Cognyte Software by 30.8% in the third quarter. Walleye Capital LLC now owns 103,009 shares of the medical device company’s stock valued at $495,000 after purchasing an additional 24,280 shares in the last quarter. GSA Capital Partners LLP increased its stake in Cognyte Software by 92.9% in the 3rd quarter. GSA Capital Partners LLP now owns 230,614 shares of the medical device company’s stock valued at $1,109,000 after buying an additional 111,039 shares during the last quarter. Finally, Sei Investments Co. lifted its position in Cognyte Software by 48.7% during the 3rd quarter. Sei Investments Co. now owns 127,220 shares of the medical device company’s stock worth $612,000 after buying an additional 41,657 shares in the last quarter. 63.27% of the stock is currently owned by institutional investors.
About Cognyte Software
Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.